Partow Kebriaei Department of Stem Cell Transplantation and Cellular Therapy U.T. MD Anderson Cancer Center Biography Publications Institution JoVE Articles Partow Kebriaei has not added a biography. If you are Partow Kebriaei and would like to personalize this page please email our Author Liaison for assistance. Publications Incidence and Natural History of Pure Red Cell Aplasia in Major ABO-mismatched Haematopoietic Cell Transplantation British Journal of Haematology. Jan, 2013 | Pubmed ID: 23330820 Feasibility of Allografting in Patients with Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab Ozogamicin Clinical Lymphoma, Myeloma & Leukemia. Jan, 2013 | Pubmed ID: 23313065 Significance of Persistent Cytogenetic Abnormalities on Myeloablative Allogeneic Stem Cell Transplantation in First Complete Remission Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Feb, 2013 | Pubmed ID: 22982533 Cord-blood Engraftment with Ex Vivo Mesenchymal-cell Coculture The New England Journal of Medicine. Dec, 2012 | Pubmed ID: 23234514 CARs in Chronic Lymphocytic Leukemia - Ready to Drive Current Hematologic Malignancy Reports. Dec, 2012 | Pubmed ID: 23225251 Dose Intensification of Busulfan in the Preparative Regimen is Associated with Improved Survival: A Phase I/II Controlled, Randomized Study Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Dec, 2012 | Pubmed ID: 23220013 Autologous Stem Cell Transplantation for Refractory Or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of The Specific High-Dose Chemotherapy Regimen On Outcome Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Nov, 2012 | Pubmed ID: 23128322 Bayesian Continual Reassessment Method for Dose-finding Trials Infusing T Cells with Limited Sample Size Journal of Biopharmaceutical Statistics. 2012 | Pubmed ID: 23075018 Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Dec, 2012 | Pubmed ID: 22796535 Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Dec, 2012 | Pubmed ID: 22750645 High-dose Infusional Gemcitabine Combined with Busulfan and Melphalan with Autologous Stem-cell Transplantation in Patients with Refractory Lymphoid Malignancies Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Nov, 2012 | Pubmed ID: 22643322 Nonmyeloablative Allogeneic Transplantation with or Without 90yttrium Ibritumomab Tiuxetan is Potentially Curative for Relapsed Follicular Lymphoma: 12-year Results Blood. Jun, 2012 | Pubmed ID: 22586182 A Foundation for Universal T-cell Based Immunotherapy: T Cells Engineered to Express a CD19-specific Chimeric-antigen-receptor and Eliminate Expression of Endogenous TCR Blood. Jun, 2012 | Pubmed ID: 22535661 The Role of Allogeneic Hematopoietic Stem Cell Transplantation in the Therapy of Patients with Acute Lymphoblastic Leukemia Current Hematologic Malignancy Reports. Jun, 2012 | Pubmed ID: 22410763 Inotuzumab Ozogamicin, an Anti-CD22-calecheamicin Conjugate, for Refractory and Relapsed Acute Lymphocytic Leukaemia: a Phase 2 Study The Lancet Oncology. Apr, 2012 | Pubmed ID: 22357140 CARs: Driving T-cell Specificity to Enhance Anti-tumor Immunity Frontiers in Bioscience (Scholar Edition). 2012 | Pubmed ID: 22202074 Infusing CD19-Directed T Cells to Augment Disease Control in Patients Undergoing Autologous Hematopoietic Stem-Cell Transplantation for Advanced B-Lymphoid Malignancies Human Gene Therapy. Jan, 2012 | Pubmed ID: 22107246 Fludarabine, Melphalan, Thiotepa and Anti-thymocyte Globulin Conditioning for Unrelated Cord Blood Transplant Leukemia & Lymphoma. May, 2012 | Pubmed ID: 21988645 Long-term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: Impact of Tyrosine Kinase Inhibitors on Treatment Outcomes Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Apr, 2012 | Pubmed ID: 21867666 Mesenchymal Stem Cell Therapy in the Treatment of Acute and Chronic Graft Versus Host Disease Frontiers in Oncology. 2011 | Pubmed ID: 22655232 Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia Resistant to Tyrosine Kinase Inhibitors Clinical Lymphoma, Myeloma & Leukemia. Jun, 2011 | Pubmed ID: 22035758 High Incidence of Vitamin D Deficiency in Patients Undergoing Allogeneic Stem Cell Transplantation American Journal of Hematology. Nov, 2011 | Pubmed ID: 21948087 Treatment of FLT3-ITD-positive Acute Myeloid Leukemia Relapsing After Allogeneic Stem Cell Transplantation with Sorafenib Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Dec, 2011 | Pubmed ID: 21767516 Evaluation and Management of BK Virus-associated Nephropathy Following Allogeneic Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Nov, 2011 | Pubmed ID: 21767514 Platelet Recovery Before Allogeneic Stem Cell Transplantation Predicts Posttransplantation Outcomes in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Dec, 2011 | Pubmed ID: 21684343 Reprogramming CD19-specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-lineage Malignancies Cancer Research. May, 2011 | Pubmed ID: 21558388 Persistence of Cytogenetic Abnormalities at Complete Remission After Induction in Patients with Acute Myeloid Leukemia: Prognostic Significance and the Potential Role of Allogeneic Stem-cell Transplantation Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jun, 2011 | Pubmed ID: 21555694 Myeloablative Reduced-toxicity I.v. Busulfan-fludarabine and Allogeneic Hematopoietic Stem Cell Transplant for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome in the Sixth Through Eighth Decades of Life Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Oct, 2011 | Pubmed ID: 21338705 Treatment of Graft-versus-host-disease with Mesenchymal Stromal Cells Cytotherapy. Mar, 2011 | Pubmed ID: 21231805 MSCs in Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jan, 2011 | Pubmed ID: 21195306 Results of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia Patients Who Failed Tyrosine Kinase Inhibitors After Developing BCR-ABL1 Kinase Domain Mutations Blood. Mar, 2011 | Pubmed ID: 21156844 Outcomes of Patients with Myeloid Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Matched Unrelated Donors Compared with One Human Leukocyte Antigen Mismatched Related Donors Using HLA Typing at 10 Loci Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jun, 2011 | Pubmed ID: 20969970 Clofarabine ± Fludarabine with Once Daily I.v. Busulfan As Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jun, 2011 | Pubmed ID: 20946966 Intravenous Busulfan Plus Melphalan is a Highly Effective, Well-tolerated Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Advanced Lymphoid Malignancies Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Mar, 2011 | Pubmed ID: 20674757 A Randomized Study Comparing Chemotherapy Followed by G-CSF Alone or in Combination with GM-CSF for Mobilization of Peripheral Blood Stem Cells in Patients with Non-Hodgkin's Lymphomas Journal of Blood Medicine. 2010 | Pubmed ID: 22282683 A High Throughput Microelectroporation Device to Introduce a Chimeric Antigen Receptor to Redirect the Specificity of Human T Cells Biomedical Microdevices. Oct, 2010 | Pubmed ID: 20574820 First Report of Phase 2 Study of Dasatinib with Hyper-CVAD for the Frontline Treatment of Patients with Philadelphia Chromosome-positive (Ph+) Acute Lymphoblastic Leukemia Blood. Sep, 2010 | Pubmed ID: 20466853 Combining CD19 Redirection and Alloanergization to Generate Tumor-specific Human T Cells for Allogeneic Cell Therapy of B-cell Malignancies Cancer Research. May, 2010 | Pubmed ID: 20424114 Reduced-intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Aug, 2010 | Pubmed ID: 20178853 PiggyBac Transposon/transposase System to Generate CD19-specific T Cells for the Treatment of B-lineage Malignancies Human Gene Therapy. Apr, 2010 | Pubmed ID: 19905893 Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Hematology/oncology Clinics of North America. Oct, 2009 | Pubmed ID: 19825452 Nonmyeloablative Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia in the Imatinib Era Clinical Lymphoma & Myeloma. 2009 | Pubmed ID: 19778850 Donor-recipient Mismatches in MHC Class I Chain-related Gene A in Unrelated Donor Transplantation Lead to Increased Incidence of Acute Graft-versus-host Disease Blood. Oct, 2009 | Pubmed ID: 19654407 Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-host Disease Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jul, 2009 | Pubmed ID: 19539211 Endpoints for Clinical Trials Testing Treatment of Acute Graft-versus-host Disease: a Joint Statement Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jul, 2009 | Pubmed ID: 19539208 Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jun, 2009 | Pubmed ID: 19450756 Poor Hematopoietic Stem Cell Mobilizers: a Single Institution Study of Incidence and Risk Factors in Patients with Recurrent or Relapsed Lymphoma American Journal of Hematology. Jun, 2009 | Pubmed ID: 19384931 Low-dose Azacitidine After Allogeneic Stem Cell Transplantation for Acute Leukemia Cancer. May, 2009 | Pubmed ID: 19235255 Therapy-related Acute Myelogenous Leukemia and Myelodysplastic Syndrome in Patients with Acute Lymphoblastic Leukemia Treated with the Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Regimens Cancer. Jan, 2009 | Pubmed ID: 19090005 Disease Staging with Positron Emission Tomography or Gallium Scanning and Use of Rituximab Predict Outcome for Patients with Diffuse Large B-cell Lymphoma Treated with Autologous Stem Cell Transplantation British Journal of Haematology. Sep, 2008 | Pubmed ID: 18564354 Secondary Myelodysplastic Syndrome in a Patient with Philadelphia-positive Acute Lymphoblastic Leukemia After Achieving a Major Molecular Response with HyperCVAD Plus Imatinib Mesylate Leukemia Research. Sep, 2008 | Pubmed ID: 18355919 Successful Autologous Stem Cell Collection in Patients with Chronic Myeloid Leukemia in Complete Cytogenetic Response, with Quantitative Measurement of BCR-ABL Expression in Blood, Marrow, and Apheresis Products Leukemia & Lymphoma. Mar, 2008 | Pubmed ID: 18297531 Modern Treatment Programs for Adults with Acute Lymphoblastic Leukemia Current Hematologic Malignancy Reports. Jul, 2007 | Pubmed ID: 20425366 Deletion of the Short Arm of Chromosome 1 (del 1p) is a Strong Predictor of Poor Outcome in Myeloma Patients Undergoing an Autotransplant Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Sep, 2007 | Pubmed ID: 17697969 Long-term Follow-up of Allogeneic Hematopoietic Stem-cell Transplantation with Reduced-intensity Conditioning for Patients with Chronic Myeloid Leukemia Blood. Nov, 2007 | Pubmed ID: 17652620 Biphenotypic Acute Leukaemia: a Case Series British Journal of Haematology. Jul, 2007 | Pubmed ID: 17593028 Novel Tyrosine Kinase Inhibitor Therapy Before Allogeneic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia: No Evidence for Increased Transplant-related Toxicity Cancer. Jul, 2007 | Pubmed ID: 17559140 Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of High-risk Acute Myelogenous Leukemia and Myelodysplastic Syndrome Using Reduced-intensity Conditioning with Fludarabine and Melphalan Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Apr, 2007 | Pubmed ID: 17382251 Fixed-dose Single Agent Pegfilgrastim for Peripheral Blood Progenitor Cell Mobilisation in Patients with Multiple Myeloma British Journal of Haematology. Jun, 2006 | Pubmed ID: 16681642 Cytokines in the Treatment of Acute Leukemias Cancer Treatment and Research. 2005 | Pubmed ID: 16209072 Multiple Unrelated Clonal Abnormalities in Host Bone Marrow Cells After Allogeneic Stem Cell Transplantation Leukemia Research. May, 2004 | Pubmed ID: 15068908 Progress and Challenges in the Therapy of Adult Acute Lymphoblastic Leukemia Current Opinion in Hematology. Jul, 2003 | Pubmed ID: 12799534 Acute Lymphoblastic Leukaemia: Diagnosis and Classification Best Practice & Research. Clinical Haematology. Dec, 2002 | Pubmed ID: 12617866 Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood M. Helen Huls1, Matthew J. Figliola1, Margaret J. Dawson1, Simon Olivares1, Partow Kebriaei2, Elizabeth J. Shpall2, Richard E. Champlin2, Harjeet Singh1, Laurence J.N. Cooper1 1Division of Pediatrics, U.T. MD Anderson Cancer Center, 2Department of Stem Cell Transplantation and Cellular Therapy, U.T. MD Anderson Cancer Center JoVE 50070 Immunologia e infezioni
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood M. Helen Huls1, Matthew J. Figliola1, Margaret J. Dawson1, Simon Olivares1, Partow Kebriaei2, Elizabeth J. Shpall2, Richard E. Champlin2, Harjeet Singh1, Laurence J.N. Cooper1 1Division of Pediatrics, U.T. MD Anderson Cancer Center, 2Department of Stem Cell Transplantation and Cellular Therapy, U.T. MD Anderson Cancer Center JoVE 50070 Immunologia e infezioni
